No Data
Moderna Shares Fall 18% After Cutting Annual R&D Spending by $1.1 Billion From 2027
S&P 500, Nasdaq Jump For 4th Straight Day As Tech Leads Stocks Higher
CSL Competitor Moderna Shifts Flu Vaccine Strategy -- Market Talk
BofA Securities Initiates Moderna(MRNA.US) With Hold Rating, Announces Target Price $110
Top Gap Ups and Downs on Thursday: SNY, DEO, GOLD and More
S&P 500 Gains and Losses Today: Moderna Stock Plunges as Firm Plans R&D Cuts